Differences in kidney prognosis between congenital and infantile nephrotic syndrome.
Inoki Y, Horinouchi T, Aoyama S, Kimura Y, Ichikawa Y, Tanaka Y, Ueda C, Kitakado H, Kondo A, Sakakibara N, Kamei K, Hamada R, Fujita N, Gotoh Y, Kaku Y, Nishiyama K, Okamoto T, Toya Y, Yamamura T, Ishimori S, Nagano C, Nozu K.
Pediatr Nephrol. 2025 Aug;40(8):2539-2549. doi: 10.1007/s00467-025-06735-z. Epub 2025 Mar 17.
PMID:40095038
Idiopathic infantile hypercalcemia in children with chronic kidney disease due to kidney hypodysplasia.
Gurevich E, Borovitz Y, Levi S, Perlman S, Landau D.
[Infantile polycystic kidney disease: a case report and literature review].
Luo F, Gu WZ, Chen Z, Shi LP, Ma XL, Lin HJ, Qiu YH.
Zhonghua Er Ke Za Zhi. 2013 May;51(5):377-81.
PMID:23941846
[Infantile polycystic kidney].
Barrera M, Quezada L.
Rev Chil Pediatr. 1986 Jan-Feb;57(1):35-8.
PMID:3532227
Chest configuration in children and adolescents with infantile nephropathic cystinosis compared with other chronic kidney disease entities and its clinical determinants.
Müller S, Kluck R, Jagodzinski C, Brügelmann M, Hohenfellner K, Büscher A, Kemper MJ, Fröde K, Oh J, Billing H, Thumfart J, Weber LT, Acham-Roschitz B, Arbeiter K, Tönshoff B, Hagenberg M, Pavičić L, Haffner D, Zivicnjak M.
Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis.
Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis.
Nießl C, Boulesteix AL, Oh J, Palm K, Schlingmann P, Wygoda S, Haffner D, Wühl E, Tönshoff B, Buescher A, Billing H, Hoppe B, Zirngibl M, Kettwig M, Moeller K, Acham-Roschitz B, Arbeiter K, Bald M, Benz M, Galiano M, John-Kroegel U, Klaus G, Marx-Berger D, Moser K, Mueller D, Patzer L, Pohl M, Seitz B, Treikauskas U, von Vigier RO, Gahl WA, Hohenfellner K.